Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,182.6
1.3 (0.04%)

 

  • STI Straits Times Index
    3,182.6
    1.3 (0.04%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,550.5
    -1.2 (-0.08%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    27,160.6
    -779.8 (-2.79%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,976.5
    -84.2 (-2.75%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    23,379.4
    163.7 (0.71%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,113.0
    1.9 (0.03%)
    Index delayed 10 minutes
  • KOR KOSPI
    2,185.3
    8.6 (0.39%)
    Index delayed 20 minutes
  • XAO XAO
    7,135.9
    37.5 (0.53%)
     

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,408.5M
  • Value: 1,025.2M
  • Rise: 211
  • Fall: 124
  • Unch: 481

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Medtecs Intl0.196+0.024
Healthway Med0.044-0.002
UG Healthcare0.375+0.125
AsiaMedic0.017-
Golden Agri-Res0.220-0.005
Genting Sing0.870-0.005
Rex Intl0.174+0.006
Thomson Medical0.063-
MarcoPolo Marine0.023+0.002
Ntegrator Intl0.012+0.001

World Indices

World Indices
Name Last Change
Nasdaq 9,269.7 +130.4
HSI 27,160.6 -779.8
HSCEI 10,618.7 -350.5
Jakarta 6,113.0 +1.9
Nikkei 225 23,379.4 +163.7
SSE Comp 2,976.5 -84.2
Shanghai A 3,118.9 -88.2
Shanghai B 248.6 -8.9
PSE Comp 0.0
KOSPI 2,185.3 +8.6

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

CT ENTERPRISE CT ENTERPRISE
Quotes 15 Minutes Delayed. Updated at 29 Jan 2020 16:08
Last (HKD): 1.740 Change: -0.030 High: 1.740 Remarks: -
Change (%): -1.69 Low: 1.740
Open 1.740 Yesterday's Close 1.770
Buy Price 1.480 Sell Price 1.740
Buy Volume ('000) 1 Sell Volume ('000) 8
Cumulative Volume ('000) - Cumulative Value -
Click to show Stock Prices chart

Key Statistics

EPS (HKD) a 0.68908 Trailing EPS (HKD) e 0.51155 NAV (HKD) b 6.2573
PE a 2.525 Trailing PE f 3.401 Price / NAV b 0.2781
Dividend (HKD) d - Cash In Hand (HKD) g 1.0523 Issued & Paid-up Shares c 240,718,000
Dividend Yield (%) d - Price / Cash In Hand g 1.654 Treasury Shares h -
Beta - 75 Daysi 0.793 R-Squared - 75 Days(%)i 6.12 Market Cap (M) 418.849
Beta - 500 Daysi 0.547 R-Squared - 500 Days (%)i 4.57 Enterprise Value (M) 465.306
Piotroski F Score 5 Exchange Code 3839 Par Value ( USD ) 0.10000
52 Weeks Volatility (%) 31.32 6-Month VWAP 1.609 Free Float (%) 26.7
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 29 Jul 2015.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 29 Jul 2015.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference CT ENTERPRISE HKEx 418.849 2.525 3.401 0.2781 -
Industry Biotechnology HKEx 47,417.529 14.589 15.581 6.2409 2.505
Local Peer AMGEN-T HKEx 594,184.000 9.032 9.399 6.9364 4.385
Local Peer SINO BIOPHARM HKEx 139,587.119 13.027 13.520 4.1570 0.659
Local Peer WUXI BIO HKEx 131,906.697 176.604 138.064 13.5781 -
Local Peer BEIGENE HKEx 95,512.095 - - 9.5298 -
Local Peer GENSCRIPT BIO HKEx 34,520.656 207.598 - 9.7349 -
Local Peer 3SBIO HKEx 26,720.484 17.663 21.499 2.6336 -
Local Peer ALPHAMAB-B HKEx 12,195.770 - - -34.2235 -
Local Peer HAOHAI BIOTEC HKEx 11,764.889 23.961 26.555 2.7700 0.884
Local Peer CKLIFE SCIENCES HKEx 7,977.188 30.336 30.294 1.9107 1.205
Local Peer FRONTAGE HKEx 8,030.560 91.158 91.151 4.1563 -
Local Peer VIVA BIOTECH HKEx 6,559.644 61.162 61.161 3.4055 -
Local Peer ASCENTAGE-B HKEx 5,452.025 - - -2.9523 -
Other Local Peers ASCLETIS-B (HKEx), SINOMAB BIO-B (HKEx), ESSEX BIO-TECH (HKEx), LEE'S PHARM (HKEx), BBI LIFE SCI (HKEx), UNI-BIO GROUP (HKEx), EXTRAWELL PHAR (HKEx), BIOSINO BIO-TEC (HKEx), REGENT PACIFIC (HKEx), HAO WEN HLDGS (HKEx)
Global Peer AMGEN INC NASDAQ 133,596.331 15.916 16.561 12.2263 2.488
Global Peer CSL ASX 141,910.746 52.894 52.894 18.9640 0.849
Global Peer GILEAD SCIENCES INC NASDAQ 81,425.054 14.927 30.236 3.9519 3.590
Global Peer VERTEX PHARMACEUTICAL NASDAQ 59,651.086 28.454 27.825 11.3548 -
Global Peer BIOGEN INC NASDAQ 50,875.622 11.483 9.429 3.6350 -
Global Peer ILLUMINA INC NASDAQ 46,199.160 55.931 47.481 10.4076 -
Global Peer REGENERON PHARMACEUTICALS INC NASDAQ 37,778.597 15.455 17.619 3.5965 -
Global Peer AGILENT TECHNOLOGIES INC NYSE 27,041.754 85.575 25.249 5.6954 0.701
Global Peer ALEXION PHARMACEUTICAL INC NASDAQ 23,671.498 305.045 16.100 2.2833 -
Global Peer SEATTLE GENETICS INC NASDAQ 19,354.621 - - 10.8758 -
Other Global Peers INCYTE CORPORATION (NASDAQ), BIOMARIN PHARMACEUTICAL (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), EXACT SCIENCES CORP (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), 10X GENOMICS INC (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), MODERNA INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), EXELIXIS INC (NASDAQ), REPLIGEN CORP (NASDAQ), BLUEBIRD BIO INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), Lonza (SGX), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), IMMUNOMEDICS INC (NASDAQ), FIBROGEN INC (NASDAQ), NEKTAR THERAPEUTICS (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), EMERGENT BIOSOLUTIONS INC (NYSE), ALKERMES PLC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), NATERA INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), UNIQURE N.V. (NASDAQ), CHEMOCENTRYX INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), VIELA BIO INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), ARVINAS INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), EPIZYME INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), XENCOR INC (NASDAQ), INSMED INC (NASDAQ), ALECTOR INC (NASDAQ), REGENXBIO INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), CORTEXYME INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), VERACYTE INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), POLYNOVO LIMITED (ASX), ROCKET PHARMACEUTICALS INC (NASDAQ), NEXTCURE INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), MYOVANT SCIENCES LTD (NYSE), ENANTA PHARMACEUTICALS INC (NASDAQ), OPKO HEALTH INC (NASDAQ), MESOBLAST LTD (ASX), KARYOPHARM THERAPEUTICS INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), DERMIRA INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), XBIOTECH INC (NASDAQ), ACHILLION PHARMACEUTICALS INC (NASDAQ), AVITA MEDICAL LTD (ASX), AVITA MEDICAL LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), INTREXON CORP (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), IMMUNOGEN INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), OMEROS CORP (NASDAQ), VANDA PHARMACE INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), CYTOKINETICS INC (NASDAQ), KADMON HLDGS INC (NYSE), AVROBIO INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), RETROPHIN INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), NANTKWEST INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), ARDELYX INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), KURA ONCOLOGY INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), NANOVIRICIDES INC (NYSE American), MAGENTA THERAPEUTICS INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), MACROGENICS INC (NASDAQ), AGENUS INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), MERUS B V (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), COMPUGEN (NASDAQ), ARCUS BIOSCIENCES INC (NYSE), MERIDIAN BIOSCIENCE INC COM (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), PROGENICS PHARMACEUTICALS INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), CABALETTA BIO INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), AVID BIOSERVICES INC (NASDAQ), RECRO PHARMA INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), PDL BIOPHARMA INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), IVERIC BIO INC (NASDAQ), PERSONALIS INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), NEUROINSIGHTS NEUROTECH (NASDAQ), STEMLINE THERAPEUTICS INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), DPHARMA (Bursa), UNITY BIOTECHNOLOGY INC (NASDAQ), MEDICINOVA INC (NASDAQ), NEXT SCIENCE LTD (ASX), SPECTRUM PHARMACEUTICALS INC (NASDAQ), GERON CORP (NASDAQ), KAMADA (NASDAQ), PFENEX INC (NYSE American), CONCERT PHARMACEUTICALS INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), TELIX PHARMACEUTIC (ASX), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), VBI VACCINES INC CDA (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), NOVAVAX INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), IMV INC (NASDAQ), ATHERSYS INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), AFFIMED N V (NASDAQ), XOMA CORP (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), CHIASMA INC (NASDAQ), NEUREN PHARMACEUTICALS LTD (ASX), PROTAGONIST THERAPEUTICS INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), LINEAGE CELL THERAPEUTICS INC (NYSE American), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), ARAVIVE INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), CONTRAFECT CORP (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), VERASTEM INC (NASDAQ), VACCINEX INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), CEL-SCI CORP (NYSE American), SAVARA INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), PYC THERAPEUTICS LIMITED (ASX), AXCELLA HEALTH INC (NASDAQ), ADURO BIOTECH INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), ENZO BIOCHEM INC (NYSE), AVALON GLOBOCARE CORP (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), RESAPP HEALTH LIMITED (ASX), CHIMERIX INC (NASDAQ), PALATIN TECHNOLOGIES INC (NYSE American), 22ND CENTURY GROUP INC (NYSE American), IMUGENE LIMITED (ASX), SESEN BIO INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), OTONOMY INC (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), COHBAR INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), ORGENESIS INC (NASDAQ), EQUILLIUM INC (NASDAQ), SYNLOGIC INC (NASDAQ), INFLARX N V (NASDAQ), TREVENA INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), VERMILLION INC (NASDAQ), CYNATA THERAPEUTICS LTD (ASX), SURFACE ONCOLOGY INC (NASDAQ), IMMUTEP LTD (ASX), ONCOSIL MEDICAL LIMITED (ASX), BELLICUM PHARMACEUTICALS (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), SYNTHETIC BIOLOGICS INC (NYSE American), MICROBOT MEDICAL INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), NEWLINK GENETICS CORP (NASDAQ), SOLIGENIX INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), ORTHOCELL LIMITED (ASX), KEZAR LIFE SCIENCES INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), INMUNE BIO INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), CURIS INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), RESTORBIO INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), ISORAY INC (NYSE American), ARMATA PHARMACEUTICALS INC (NYSE American), ADVAXIS INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), NEON THERAPEUTICS INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), VAXART INC (NASDAQ), ZAFGEN INC (NASDAQ), EVOGENE LTD (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), BIOTRON (ASX), INVEX THERAPEUTICS LTD NPV (ASX), ITERUM THERAPEUTICS PLC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), BIOCARDIA INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), OCUGEN INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), BIONANO GENOMICS INC (NASDAQ), AEVI GENOMIC MEDIC (NASDAQ), INNOVATE BIOPHARMACEUTICALS INC (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), KAZIA THERAPEUTICS LIMITED (ASX), APTEVO THERAPEUTICS INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), SOPHIRIS BIO INC (NASDAQ), GENETIC TECHNOLOGIES (ASX), ANTEOTECH LIMITED (ASX), ACTINOGEN MEDICAL LTD (ASX), DARE BIOSCIENCE INC (NASDAQ), BIONOMICS LTD (ASX), MEMPHASYS LTD (ASX), CELLECTAR BIOSCIENCES INC (NASDAQ), TALI DIGITAL LIMITED (ASX), SIERRA ONCOLOGY INC (NASDAQ), IBIO INC (NYSE American), AETERNA ZENTARIS INC (NASDAQ), ATYR PHARMA INC (NASDAQ), ACTINIUM PHARMACEUTICALS INC (NYSE American), ORAGENICS INC (NYSE American), RHINOMED LIMITED (ASX), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), CCP TECHNOLOGIES LTD (ASX), INDIA GLOBALIZATION CAPITAL INC (NYSE American), BIO-PATH HOLDINGS INC (NASDAQ), PROTEOMICS INTL LABORATORIES LTD (ASX), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 20 ORD SHS(R/S) (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), PRECIPIO INC (NASDAQ), IMMURON LIMITED (ASX), CORREVIO PHARMA CORP (NASDAQ), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), CELLMID LIMITED (ASX), PRESCIENT THERAPEUTICS LIMITED (ASX), PATRYS LIMITED (ASX), DIFFUSION PHARMACEUTICALS INC (NASDAQ), Suntar Eco-City^ (SGX), HEAT BIOLOGICS INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), TROVAGENE INC (NASDAQ), CONATUS PHARMACEUTICALS INC (NASDAQ), BIOCEPT INC (NASDAQ), CONTANGO ASSET MANAGEMENT LIMITED (ASX), REGENEUS LTD (ASX), TOCAGEN INC (NASDAQ), ANATARA LIFESCIENCES LTD (ASX), CYCLACEL PHARMA IN (NASDAQ), HOLISTA COLLTECH LIMITED (ASX), ALTERITY THERAPEUTICS LIMITED (ASX), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), SENESTECH INC (NASDAQ), ADALTA LTD (ASX), SIENNA CANCER DIAGNOSTICS LTD (ASX), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), NOVABAY PHARMACEUTICALS INC (NYSE American), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), ARCA BIOPHARMA INC (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), LIVING CELL TECHNOLOGIES (ASX), OPGEN INC (NASDAQ), AIM IMMUNOTECH INC (NYSE American), BENITEC BIOPHARMA LTD SPON ADS EA REPR 200 ORD SHS(POST SPLIT) (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), BENITEC BIOPHARMA LTD (ASX), BIOXYNE LIMITED (ASX), AUSTRALIAN PRIMARY HEMP LTD (ASX), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), MGRC (Bursa), QT Vascular (SGX), PHIO PHARMACEUTICALS CORP (NASDAQ), MEDIBIO LIMITED (ASX), SPHERIX INC (NASDAQ), TBG DIAGNOSTICS LTD (ASX), AURIS MEDICAL HOLDING LTD (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), AVECHO BIOTECHNOLOGY LTD (ASX), AMPLIA THERAPEUTICS LTD (ASX), THERAPIX BIOSCIENCES LTD SPON ADR EACH REP 40 ORD (POST SPLIT) (NASDAQ), NANOLLOSE LTD (ASX), BPH ENERGY LIMITED (ASX), FACTOR THERAPEUTICS LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.040
-2.25 %
10 Days -+0.240
+16.00 %
20 Days -+0.260
+17.57 %
Medium Term Return 3 Months -+0.150
+9.43 %
6 Months --0.040
-2.25 %
1 Year --0.190
-9.84 %
Long Term Return 2 Years --0.750
-30.12 %
3 Years --0.660
-27.50 %
Annualised Return Annualised --
-10.16 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 1.340 - 2.150 Change From 1 Year Low +0.400 % Change From 1 Year Low (%) +29.85
Change From 1 Year High -0.410 % Change From 1 Year High (%) -19.07
2 Years Range 1.340 - 2.850 Change From 2 Years Low +0.400 % Change From 2 Years Low (%) +29.85
Change From 2 Years High -1.110 % Change From 2 Years High (%) -38.95
5 Years Range 1.340 - 8.000 Change From 5 Years Low +0.400 % Change From 5 Years Low (%) +29.85
Change From 5 Years High -6.260 % Change From 5 Years High (%) -78.25
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Chia Tai Enterprises International Ltd. engages in the manufacturing and sale of chlortetracycline products, trading of machinery and manufacturing and sale of automotive parts. It operates through the following two segments: Biochemical Operation and Industrial Operation. The Biochemical Operation segment manufactures and sells chlortetracycline products. The Industrial Operation segment trades machinery; and produces and markets automotive parts, through the joint venture and associate. The company was founded on October 16, 1987 and is headquartered in Hong Kong.

Historical Price Data

Date Open High Low Close Volume VWAP
24 Jan 2020 1.770 1.770 1.770 1.770 - -
23 Jan 2020 1.770 1.770 1.770 1.770 100 1.9200
22 Jan 2020 1.650 1.780 1.580 1.770 56,600 1.5970
21 Jan 2020 1.690 1.700 1.660 1.660 51,500 1.6695
20 Jan 2020 1.890 2.000 1.780 1.790 207,040 1.8534
17 Jan 2020 1.600 1.780 1.600 1.780 208,840 1.7497
16 Jan 2020 1.620 1.620 1.620 1.620 - -
15 Jan 2020 1.720 1.720 1.650 1.660 23,620 1.7188
14 Jan 2020 1.650 1.730 1.650 1.720 315,400 1.7179
13 Jan 2020 1.500 1.550 1.500 1.550 2,300 1.5848
10 Jan 2020 1.460 1.500 1.460 1.500 5,120 1.4756
09 Jan 2020 1.600 1.600 1.500 1.500 9,600 1.5638
08 Jan 2020 1.540 1.540 1.440 1.440 3,700 1.5454
07 Jan 2020 1.450 1.490 1.430 1.490 35,500 1.4661
06 Jan 2020 1.450 1.450 1.450 1.450 500 1.4500
03 Jan 2020 1.480 1.480 1.480 1.480 3,500 1.4800
02 Jan 2020 1.520 1.540 1.520 1.520 13,500 1.5281
31 Dec 2019 1.500 1.500 1.500 1.500 5,000 1.5000
30 Dec 2019 1.480 1.480 1.480 1.480 - -
27 Dec 2019 1.450 1.480 1.450 1.480 2,100 1.5448
24 Dec 2019 1.450 1.450 1.450 1.450 - -
23 Dec 2019 1.430 1.430 1.430 1.430 8,000 1.4300
Summary
Current 2 Weeks
(13 Jan 2020 to 24 Jan 2020)
1.500 2.000 1.500 1.770 865,400 -
Previous 2 Weeks
(27 Dec 2019 to 10 Jan 2020)
1.450 2.000 1.450 1.500 78,520 -
4 Weeks from
(27 Nov 2019 to 24 Dec 2019)
1.380 2.000 1.340 1.450 325,651 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.